Publication:
Impact of Eculizumab on Hospitalization Rates and Relapse Treatment in Patients with AQP4+NMOSD: The Phase 3 PREVENT Study

Research Projects

Organizational Units

Journal Issue

Abstract

Description

Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Forum -- FEB 27-29, 2020 -- West Palm Beach, FL

Keywords

Citation

WoS Q

Scopus Q

Source

Volume

26

Issue

Start Page

105

End Page

105

Endorsement

Review

Supplemented By

Referenced By